Our study offers tantalizing hope of clinical implications: This study displays that GBE has a promising effect in treating animals in which HFD coexists with depression by reducing cardiac and brain inflammation via the canonical NF-κB signaling pathway. The gene discussed is NFKB1; the disease is major depressive disorder.